ヨーロッパの経腸栄養の市場規模および予測（2021年〜2031年）、地域シェア、動向、成長機会分析レポート：製品タイプ別、国別

レポートナンバー　0000040747

ヨーロッパの経腸栄養の市場規模および予測（2021年〜2031年）、地域シェア、動向、成長機会分析レポート：製品タイプ別、国別

The Insight Partners

Europe Enteral Nutrition Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Nasogastric, Nasoenteral, Sipping, and Others) and Country

発刊日 2024/12/20

言語英語

体裁PDF/124ページ

ライセンス/価格124ページ

0000040747

Single	3,450USD
Site	4,450USD
Enterprise	5,450USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

ヨーロッパの経腸栄養市場規模は、2023年の33億2,000万米ドルから2031年までに57億9,000万米ドルに達すると予測されています。市場は2023年から2031年にかけて7.2%のCAGRを記録すると予想されています。

標準化された配合と植物ベースの栄養製品

消費者が自分の健康を積極的に管理するのに役立つ製品、特にエネルギーレベル、免疫力、病気の治療に関する特定のニーズに焦点を当てた製品に対する需要が急増しています。経腸製品の機能性と特定の配合は、患者の既存の治療を妨げません。経腸栄養の多量栄養素と微量栄養素の配合とその応用は、検討中の疾患に応じて異なります。等カロリーの経腸栄養製剤（1 kcal/ml）は通常、推定または測定されたカロリー目標を達成するために処方されますが、エネルギー密度の高い製剤（> 1 kcal/ml）は胃腸機能不全の患者のカロリー送達を増やすために処方されます。

標準化された経腸栄養製品には固定成分が含まれており、年齢層ごとに要件が異なることを考慮して、患者の平均的な栄養要件を満たすように設計されています。たとえば、ペプタメンフォーミュラ（Nestle社）は、経管栄養不耐症の克服に役立つ、酵素加水分解された100%ホエータンパク質を含む唯一のペプチドベースのフォーミュラです。このような経管栄養製剤は、胃腸障害のある人の吸収をサポートし、耐性機構を克服するように設計された特殊な経腸栄養製品です。

植物ベースの食品に注目する人の数の急増により、世界中で植物ベースの栄養製品の需要が高まっています。人々は、副作用を引き起こす可能性があるため、大量に使用される人工/合成原料に対してますます不寛容になっています。 Innova Consumer Survey 2020では、人々が植物ベースの代替品を検討する最大の理由として、健康、食事の多様性、持続可能性、味が挙げられています。Abbott社は、経管栄養に依存している消費者と患者はこれらのパラメータにも大きな注意を払っていると述べています。ヨーロッパの経腸栄養市場の企業は、さまざまな層で健康食品に対する嗜好が高まっていることを利用しています。その結果、Kate Farms社、Functional Formularies社、Real Food Blends社などの企業は、より自然な植物ベースの経腸製品を開発しました。2021年8月、Kate Farms社は、すぐに掛けられる容量1 Lのバッグで植物由来のミルクを提供する初の閉鎖型給餌システムを発売しました。Kate Farm社のスタンダード1.4プレーンおよびペプチド1.5プレーン製剤は、植物ベースのオーガニックで高カロリーの製品で、経管栄養における唯一の補助栄養源として使用されます。2021年9月、Abbott社は子供と大人向けの植物ベースのタンパク質とオーガニック食品原料のポートフォリオを導入しました。

したがって、機能的で患者中心の製剤と植物ベースの栄養製品が、ヨーロッパの経腸栄養市場における主要な新興トレンドとなっています。

フランスの経腸栄養市場分析

2023年3月に掲載されたLe Monde社の記事によると、フランスにおける60歳以上の人口の割合は、2023年の約20%から2050年までに約30%に急増すると予想されています。85歳以上の人口は、2030年から2050年の間に90%近く増加すると予想されます。高齢者は、糖尿病、心血管疾患、神経障害（脳卒中、パーキンソン病、アルツハイマー病など）などの慢性疾患を患っていることがよくあります。これらの状態では、正常に食べる能力が損なわれ、栄養失調につながり、経腸栄養が必要になる可能性があります。世界がん観測所（Global Cancer Observatory）によると、フランスでは2022年に48万3,568人の新規がん症例が報告され、有病者数（5年間）は1,49万4,814人でした。がんと経腸栄養は密接に関係しています。多くのがん患者は、病気自体や受けた治療が原因で栄養失調に陥り、必須栄養素を食べて吸収する能力が損なわれる可能性があります。

Fresenius Kabir France社は、経管栄養、経口栄養補助食品（ONS）、粉末製品など、すぐに使用できる経腸栄養製品の多様なポートフォリオを提供しています。同社は、嚥下障害のある患者向けに、さまざまな患者の個別のニーズを満たすために、食感を変更したさまざまな濃度の製品を提供しています。

ヨーロッパの経腸栄養市場レポートのセグメンテーション分析

ヨーロッパの経腸栄養市場分析に貢献した主要なセグメントは、タイプ、材料、エンドユーザーです。

製品タイプに基づいて、ヨーロッパの経腸栄養市場は経鼻胃、経鼻経腸、飲用、その他に分類されます。経鼻胃セグメントは2023年に市場で最大のシェアを獲得

ヨーロッパの経腸栄養市場で活動している著名なプレーヤーとしては、Nestlé、Danone S.A.、Abbott Laboratories、Friesland Campina、Fresenius SE and Co. KGaA、B. Braun SE,、Dr. Schär AG、Arla Food、Reckitt Benckiser、Perrigo Company PLC、Fonterra Co-operative Group Limited、Kate Farms、Nutritional Medicinals, LLC などが挙げられます。

企業は、ヨーロッパの経腸栄養市場規模での地位を維持するために、新しく革新的な製品やサービスを発売しています。2021年11月、Abbott社は免疫システム、消化器の健康、脳の発達をサポートするSimilac 360 Total Careを発売しました。Similac 360 Total Careは、これまで母乳中にのみ一緒に含まれていた5つの異なるHMOをブレンドした、アメリカ初で唯一の乳児用調製粉乳です。このミルクは、免疫系、消化器系、脳の発達を含む、赤ちゃん全体の健康と発達をサポートする栄養を提供するように設計されています。

レポート詳細

5. Europe Enteral Nutrition Market - Key Market Dynamics
5.1 Europe Enteral Nutrition Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Gastrointestinal Diseases
5.2.2 Rising Cases of Malnutrition and Premature Births
5.3 Market Restraints
5.3.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Feeding Systems
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Key Market Players
5.5 Future Trends
5.5.1 Standardized Formulations and Plant-Based Nutrition Products
5.6 Impact of Drivers and Restraints:

6. Europe Enteral Nutrition Market Analysis
6.1 Europe Enteral Nutrition Market Revenue (US$ Million), 2021-2031
6.2 Europe Enteral Nutrition Market Forecast and Analysis
6.3 Enteral and Parenteral Market Value (%)

7. Europe Enteral Nutrition Market Analysis - by Product Type
7.1 Nasogastric
7.1.1 Overview
7.1.2 Nasogastric: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
7.1.3 Standard
7.1.3.1 Overview
7.1.3.2 Standard: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
7.1.4 Disease Specific
7.1.4.1 Overview
7.1.4.2 Disease Specific: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Nasoenteral
7.2.1 Overview
7.2.2 Nasoenteral: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Sipping
7.3.1 Overview
7.3.2 Sipping: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Enteral Nutrition Market - Country Analysis
8.1 Europe
8.1.1 Europe Enteral Nutrition Market Breakdown by Countries
8.1.2 Europe Enteral Nutrition Market Revenue and Forecast and Analysis - by Country
8.1.2.1 Europe Enteral Nutrition Market Revenue and Forecast and Analysis - by Country
8.1.2.2 Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
8.1.2.2.1 Germany: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.2.2 Germany: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.2.3 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.2.4 Germany: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.2.5 Germany: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.2.6 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.2.7 Germany: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.3 United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
8.1.2.3.1 United Kingdom: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.3.2 United Kingdom: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.3.3 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.3.4 United Kingdom: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.3.5 United Kingdom: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.3.6 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.3.7 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.4 France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
8.1.2.4.1 France: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.4.2 France: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.4.3 France: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.4.4 France: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.4.5 France: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.4.6 France: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.4.7 France: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.5 Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
8.1.2.5.1 Italy: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.5.2 Italy: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.5.3 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.5.4 Italy: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.5.5 Italy: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.5.6 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.5.7 Italy: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.6 Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
8.1.2.6.1 Spain: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.6.2 Spain: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.6.3 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.6.4 Spain: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.6.5 Spain: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.6.6 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.6.7 Spain: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.7 Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
8.1.2.7.1 Czech Republic: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.7.2 Czech Republic: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.7.3 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.7.4 Czech Republic: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.7.5 Czech Republic: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.7.6 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.7.7 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.8 Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
8.1.2.8.1 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.8.2 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.8.3 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.8.4 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.8.5 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.8.6 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.8.7 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By End User

9. Industry Landscape
9.1 Overview
9.2 Growth Strategies in Europe Enteral Nutrition Market
9.3 Organic Growth Strategies
9.3.1 Overview
9.4 Inorganic Growth Strategies
9.4.1 Overview

10. Company Profiles
10.1 Nestle SA
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Danone SA
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Abbott Laboratories
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Royal FrieslandCampina NV
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Fresenius SE & Co KGaA
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 B Braun SE
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Reckitt Benckiser Group Plc
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Kate Farms Inc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Dr Schar AG
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Fonterra Co-Operative Group Ltd
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
10.11 Arla Foods amba
10.11.1 Key Facts
10.11.2 Business Description
10.11.3 Products and Services
10.11.4 Financial Overview
10.11.5 SWOT Analysis
10.11.6 Key Developments
10.12 Perrigo Co Plc
10.12.1 Key Facts
10.12.2 Business Description
10.12.3 Products and Services
10.12.4 Financial Overview
10.12.5 SWOT Analysis
10.12.6 Key Developments
10.13 Charing Cross Scientific AS
10.13.1 Key Facts
10.13.2 Business Description
10.13.3 Products and Services
10.13.4 Financial Overview
10.13.5 SWOT Analysis
10.13.6 Key Developments
10.14 Bexen Medical
10.14.1 Key Facts
10.14.2 Business Description
10.14.3 Products and Services
10.14.4 Financial Overview
10.14.5 SWOT Analysis
10.14.6 Key Developments

11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms

LIST OF TABLES
Table 1. Europe Enteral Nutrition Market Segmentation
Table 2. Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 4. Sipping: Europe Enteral Nutrition Market, By Type (US$ Mn)
Table 5. Sipping: Europe Enteral Nutrition Market, By Standadr by Calories (US$ Mn)
Table 6. Sipping: Europe Enteral Nutrition Market, By Isocaloric (US$ Mn)
Table 7. Sipping: Europe Enteral Nutrition Market, By Hypercaloric (US$ Mn)
Table 8. Sipping: Europe Enteral Nutrition Market, By Standard by Type (US$ Mn)
Table 9. Sipping: Europe Enteral Nutrition Market, By Standard End User (US$ Mn)
Table 10. Sipping: Top 5 Europe Enteral Nutrition Markets (US$ Mn)
Table 11. Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Country
Table 12. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 13. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
Table 14. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
Table 15. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
Table 16. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
Table 17. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
Table 18. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
Table 19. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 20. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
Table 21. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
Table 22. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
Table 23. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
Table 24. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
Table 25. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
Table 26. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 27. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
Table 28. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
Table 29. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
Table 30. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
Table 31. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
Table 32. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
Table 33. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 34. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
Table 35. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
Table 36. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
Table 37. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
Table 38. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
Table 39. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
Table 40. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 41. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
Table 42. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
Table 43. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
Table 44. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
Table 45. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
Table 46. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
Table 47. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 48. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
Table 49. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
Table 50. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
Table 51. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
Table 52. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
Table 53. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
Table 54. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 55. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
Table 56. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
Table 57. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
Table 58. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
Table 59. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
Table 60. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
Table 61. Recent Organic Growth Strategies in Europe Enteral Nutrition Market
Table 62. Recent Inorganic Growth Strategies in the Europe Enteral Nutrition Market
Table 63. Glossary of Terms, Europe Enteral Nutrition Market

LIST OF FIGURES
Figure 1. Europe Enteral Nutrition Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Enteral Nutrition Market Revenue (US$ Million), 2021-2031
Figure 5. Europe Enteral Nutrition Market Share (%) - by Product Type, 2023 and 2031
Figure 6. Nasogastric: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Standard: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Disease Specific: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Nasoenteral: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Sipping: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Europe Enteral Nutrition Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 13. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Growth Strategies in Europe Enteral Nutrition Market

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000040747

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。